CLOs on the Move

SugarCRM

www.sugarcrm.com

 
SugarCRM enables businesses to create extraordinary customer relationships with the most innovative, flexible and affordable CRM solution in the market. The company uniquely places the individual at the center of its solution—helping businesses transform the customer experience and enable highly personalized interactions that drive customer excellence and loyalty throughout the entire customer lifecycle. SugarCRM delivers a fully transformed, personalized user experience that is immersive, engaging and intuitive. Sugar fuses the straightforward simplicity, mobility and social aspects of a consumer app with the business process optimization of conventional CRM. Recognized by leading market analysts as a CRM visionary and innovator, Sugar is ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.sugarcrm.com
  • 10050 North Wolfe Road SW2-130
    Cupertino, CA USA 95014
  • Phone: 408.454.6900

Executives

Name Title Contact Details
Ray Campbell
 General Counsel Profile

Similar Companies

S1

S1 Corporation delivers integrated financial services on an open platform for financial institutions, retailers and processors.

Tycoon Unlimited

Tycoon Unlimited is a Los Angeles, CA-based company in the Software and Internet sector.

New Village Media

New Village Media is a Columbia, MD-based company in the Software and Internet sector.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.

NYDLA.org

The NYDLA mission: To support a global forum dedicated to the exchange of ideas and information between corporate, academic, and government professionals, concerning the issues and technological changes in the field of Digital, Distance or “e-Learning”...